Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma

被引:108
|
作者
Guo, Weijie [1 ,2 ]
Zhao, Yingjun [1 ]
Zhang, Zhenfeng [1 ]
Tan, Ning [1 ]
Zhao, Fangyu [1 ]
Ge, Chao [1 ]
Liang, Linhui [1 ]
Jia, Deshui [1 ,2 ]
Chen, Taoyang [4 ]
Yao, Ming [1 ,3 ]
Li, Jinjun [1 ]
He, Xianghuo [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, Lab Expt Pathol,Sch Med, Shanghai 200032, Peoples R China
[4] Qi Dong Liver Canc Inst, Qi Dong 226200, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
xCT; ROS; Autophagy; Tumorigenecity; Hepatocellular carcinoma; AMINO-ACID TRANSPORTERS; CYSTINE UPTAKE; GLUTATHIONE LEVELS; SYSTEM X(C)(-); CANCER CELLS; GLUTAMATE; SULFASALAZINE; THERAPY; REQUIREMENT; MACROPHAGES;
D O I
10.1016/j.canlet.2011.07.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
xCT, the functional subunit of the system x(c)(-) which plays an important role in maintaining intracellular glutathione (GSH) levels, is expressed in various malignant tumors. Here, we demonstrated that xCT expression is often elevated in HCC and is associated with poor prognosis in HCC patients; moreover, disruption of xCT suppressed HCC cell growth both in vitro and in vivo. xCT dysfunction has also been shown to increase intracellular reactive oxygen species (ROS) levels, thus in turn led to autophagic cell death of HCC cells. Taken together, these findings suggest that xCT may be a promising therapeutic target for human HCC. (C) 2011 Published by Elsevier Ireland Ltd.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 50 条
  • [41] Bigelovin inhibits hepatocellular carcinoma cell growth and metastasis by regulating the MAPT-mediated Fas/FasL pathway
    Wang, Bei
    Nie, Chun-Hui
    Xu, Jun
    Wan, Da-Long
    Xu, Xiao
    He, Jiang-Juan
    NEOPLASMA, 2023, 70 (02) : 208 - 215
  • [42] Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
    Yu, Vivian W. L.
    Ho, Wing Shing
    ONCOLOGY REPORTS, 2013, 29 (06) : 2205 - 2210
  • [43] Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma
    Feng, Fan
    Pan, Lianhong
    Wu, Jiaqin
    Liu, Mingying
    He, Long
    Yang, Li
    Zhou, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice
    Hong-wei Chen
    A-ling Shen
    Li-ya Liu
    Jun Peng
    Jian-feng Chu
    Chinese Journal of Integrative Medicine, 2020, 26 : 370 - 374
  • [45] Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice
    CHEN Hong-wei
    SHEN A-ling
    LIU Li-ya
    PENG Jun
    CHU Jian-feng
    Chinese Journal of Integrative Medicine, 2020, (05) : 370 - 374
  • [46] CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway
    Bi, Jianqiang
    Liu, Quanle
    Sun, Yunchuan
    Hu, Xiuru
    He, Xinying
    Xu, Chengzhen
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2021, 41 (06) : 593 - 603
  • [47] Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice
    Chen Hong-wei
    Shen, A-ling
    Liu Li-ya
    Peng, Jun
    Chu Jian-feng
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (05) : 370 - 374
  • [48] Downregulation of USP12 inhibits tumor growth via the p38/MAPK pathway in hepatocellular carcinoma
    Liu, Chunsheng
    Li, Xiaoning
    Feng, Gang
    Cao, Minggang
    Liu, Fahu
    Zhang, Guihua
    Lu, Yong
    MOLECULAR MEDICINE REPORTS, 2020, 22 (06) : 4899 - 4908
  • [49] Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice
    CHEN Hongwei
    SHEN Aling
    LIU Liya
    PENG Jun
    CHU Jianfeng
    Chinese Journal of Integrative Medicine, 2020, 26 (05) : 370 - 374
  • [50] Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway
    Cao, Jun
    Tong, Chuang
    Liu, Yanyan
    Wang, Jianguo
    Ni, Xiaoyan
    Xiong, Mao-ming
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 450 - 458